You seem to know a lot about AHZ, that $18M funding for 60% stake in their immunotheraphy product, is there any restriction on how they can spend it, they withdrew another $500K this quarter to total $1M. Can they use a majority of this for operation and staff cost in this sector for next quarter or is there a restriction as that estimated cash outflow of $15M next quarter.......
- Forums
- ASX - By Stock
- AVR
- Require regular updates
Require regular updates, page-6
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$11.68 |
Change
-0.320(2.67%) |
Mkt cap ! $246.9M |
Open | High | Low | Value | Volume |
$11.57 | $11.81 | $11.42 | $152.5K | 13.10K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 116 | $11.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.68 | 188 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 116 | 11.500 |
1 | 1000 | 11.400 |
1 | 2 | 11.260 |
1 | 8 | 11.220 |
2 | 1045 | 11.200 |
Price($) | Vol. | No. |
---|---|---|
11.680 | 188 | 1 |
11.700 | 1351 | 1 |
11.900 | 1000 | 1 |
12.000 | 4817 | 1 |
12.400 | 198 | 1 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online